Your patients expect you to KNOW.
Maybe Hydroxychloroquine will prove to be an appropriate treatment for COVID-19. Maybe it won't.  But with all the attention it's receiving in the media right now, there's a good chance that you're being asked about it by patients or other healthcare professionals.  They expect you to know.
That's why we're offering a webinar next Thursday on Hydroxychloroquine. It will include an update on the latest literature, just in time for those questions you're fielding. Think of it as a refresher as well as a briefing on recent studies and trials that may have bearing in the current debate about the drug - so that you'll feel more confident in understanding and answering questions about its current place in therapy.
 

APC is the voice for pharmacy compounding, representing compounding pharmacists, technicians, educators, students, researchers and suppliers. Compounding exists for patients and animals who are not served by traditional pharmaceutical manufacturers. Every day, APC members play a critical, often life-or-death role in patients' lives, creating essential medications unavailable elsewhere for a range of issues, including autism, oncology, dermatology, ophthalmology, pediatrics, women's health, and others.  Learn more at www.a4pc.org.